首页> 外文期刊>Fundamental & clinical pharmacology. >Antiplatelet drugs in the elderly: Prescriptions often inappropriate and reduced tolerance by associated diseases and drugs
【24h】

Antiplatelet drugs in the elderly: Prescriptions often inappropriate and reduced tolerance by associated diseases and drugs

机译:老年人抗血小板药物:处方通常不适当,并且伴随相关疾病和药物的耐受性降低

获取原文
获取原文并翻译 | 示例
       

摘要

To assess the conditions of prescriptions and tolerance of antiplatelet drugs (APD) in the elderly and to detail the parameters that influence the tolerance of these drugs. Prospective survey in a Department of Geriatric Medicine. Two hundred nineteen patients 70years and older treated with one or two APD prior to admission were included during 7months in 2008. We recorded the type of APD, associated diseases, main associated or co-prescribed drugs which could interact with APD and the bleeding adverse events including cutaneous bleeding. The mean age of the 219 patients was 84.5±6.7years (70-101years), women 59.4%. Among patients 64.8% received aspirin (mainly 75mg), 28.3% received clopidogrel and 6.8% received their combination; 16.9% of prescriptions were off-label; 51.6% of patients had an associated disease and/or an associated drug which could have increased risk of bleeding event. Among the patients who received a gastric-protective drug, the prescription followed the recommendations of the French Health Authority in 38.9%. We recorded bleeding events in 24.2% of patients at admission and in 18.3% of patients during the hospitalization. Bleeding events were significantly more frequent in patients treated with aspirin than clopidogrel (40.8 vs. 24.2%, P<0.05) and/or with an associated drug (OR=2.36, 95% CI 1.34-4.14, P<0.01) and/or an associated disease (OR=1.22, 95% CI 1.01-3.42, P<0.05). APD treatment was stopped in 28.8% of patients, mainly because lack of indication or bleeding adverse events. Off-label prescriptions of APD were not rare in the elderly, and adverse events are frequent. The results of this preliminary study evoke that medical situations at increased risk of bleeding are perhaps insufficiently evaluated, either in case of prescription of associated drugs with increased bleeding risk or during the follow-up of patients with associated diseases. Cutaneous bleeding events should be more taken into account in prospective studies.
机译:评估老年人的处方条件和抗血小板药物(APD)的耐受性,并详细说明影响这些药物耐受性的参数。在老年医学系进行前瞻性调查。在2008年的7个月中,纳入了21名70岁及以上在入院前接受过一两次APD治疗的患者。我们记录了APD的类型,相关疾病,可能与APD相互作用的主要相关药物或共同处方药以及出血不良事件包括皮肤出血。 219名患者的平均年龄为84.5±6.7岁(70-101岁),女性为59.4%。在患者中,有64.8%的患者接受了阿司匹林(主要为75mg),28.3%的患者接受了氯吡格雷和6.8%的患者接受了他们的联合用药。 16.9%的处方不合格; 51.6%的患者患有相关疾病和/或相关药物,可能会增加出血事件的风险。在接受胃保护药物的患者中,该处方遵循法国卫生局的建议,占38.9%。我们记录了入院时24.2%的患者和住院期间18.3%的患者的出血事件。阿司匹林治疗的患者出血事件的发生率明显高于氯吡格雷(40.8 vs. 24.2%,P <0.05)和/或相关药物(OR = 2.36,95%CI 1.34-4.14,P <0.01)和/或相关疾病(OR = 1.22,95%CI 1.01-3.42,P <0.05)。 28.8%的患者停止了APD治疗,主要是因为缺乏适应症或出血性不良事件。 APD的不合格处方在老年人中并不罕见,并且不良事件频繁发生。这项初步研究的结果表明,在开处方出血风险增加的相关药物的情况下或在对相关疾病患者进行随访期间,对出血风险增加的医疗状况的评估可能不够。在前瞻性研究中应更多考虑皮肤出血事件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号